Loading...

True-Nuclear™ Transcription Factor Buffer Set

Pricing & Availability
Regulatory Status
RUO
Other Names
Transcription Factor Fixation/Permeabilization Buffer Set
Ave. Rating
Submit a Review
Product Citations
publications
Transcription_Factor_F_P_Buffer_1_ICFC_012915
Human peripheral blood lymphocytes were surface stained with CD3 APC and then treated with True-Nuclear™ Transcription Factor Buffer Set. Cells were then stained with T-bet (clone 4B10) Brilliant Violet 421™ (top) or mouse IgG1, κ Brilliant Violet 421™ isotype control (bottom).
  • Transcription_Factor_F_P_Buffer_1_ICFC_012915
    Human peripheral blood lymphocytes were surface stained with CD3 APC and then treated with True-Nuclear™ Transcription Factor Buffer Set. Cells were then stained with T-bet (clone 4B10) Brilliant Violet 421™ (top) or mouse IgG1, κ Brilliant Violet 421™ isotype control (bottom).
  • Transcription_Factor_F_P_Buffer_2_ICFC_012915
Cat # Size Price Quantity Check Availability Save
424401 120 tests $165
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

BioLegend's True-Nuclear™ Transcription Factor Buffer Set has been specially formulated for intracellular staining with minimum effect on the surface fluorochrome staining.

See the advantages of True-Nuclear™ Transcription Factor Buffer Set in this brief webinar: biolegend.com/true_nuclear_webinar.


 

Caution: The True-Nuclear™ Transcription Factor Buffer Set contains paraformaldehyde, which is toxic and mutagenic. Please handle with caution. Wear gloves, lab coats, and necessary protection to avoid direct contact. 

Product Details
Technical data sheet

Product Details

Storage & Handling
Store between 2°C and 8°C. Do not freeze.
Application

ICFC - Quality tested
Recommended Usage

Prepare fresh Transcription Factor Fix working solution by diluting the 4X Fix Concentrate (1 part) with the Fix Diluent (3 parts). 1 mL of the 1X Fix working solution is needed for each tube.

Prepare a 1X working solution of the Perm Buffer by diluting the 10X Perm Buffer with distilled water. 6.5 mL of 1X Perm Buffer is needed for each sample of tube.

NOTE: The 10X Perm Buffer may have crystallization or precipitation when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is a heavy precipitation observed after dilution to 1X working solution, it can be filtered to clarify the solution.

Application Notes

Buffer Set Contents:

  • True-Nuclear™ 4X Fix Concentrate (30 mL)
  • True-Nuclear™ Fix Diluent (100 mL)
  • True-Nuclear™ 10X Perm Buffer (100 mL)

 

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells, to detect transcription factors, and to study TIGIT in our Scientific Poster Library.

Product Citations
  1. Wang L, et al. 2019. Front Pharmacol. 1.342361111. PubMed
  2. Ogawa T, et al. 2020. J Immunol. 205:907. PubMed
  3. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  4. Manso BA, et al. 2021. STAR Protoc. 2:100485. PubMed
  5. Wu HJ, et al. 2021. Nat Commun. 12:4897. PubMed
  6. Zeng N, et al. 2022. EMBO Rep. 23:e53302. PubMed
  7. Douglass SM, et al. 2021. Cancer Res. 81:658. PubMed
  8. Capelle CM, et al. 2022. Immunology. 165:428. PubMed
  9. Ellis GI, et al. 2022. Cell Rep Med. 3:100614. PubMed
  10. Grant NL, et al. 2022. Cell Rep. 39:110826. PubMed
  11. Hu M, et al. 2022. Int J Mol Sci. 23: . PubMed
  12. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  13. Yu H, et al. 2022. Hematol Oncol. 40:894. PubMed
  14. Ogishi M, et al. 2023. J Exp Med. 220: . PubMed
  15. Isildar B, et al. 2022. Inflamm Regen. 42:55. PubMed
  16. Noman MZ, et al. 2022. Front Immunol. 13:980704. PubMed
  17. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  18. Ishii T, et al. 2022. Cell Death Discov. 8:480. PubMed
  19. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  20. Weng S, et al. 2022. Front Immunol. 13:1025931. PubMed
  21. Landshammer A, et al. 2023. Elife. 12: . PubMed
  22. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  23. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  24. Rustagi Y, et al. 2022. Diabetes. 71:1149. PubMed
  25. Zander R, et al. 2022. Immunity. 55:475. PubMed
  26. de Lemos L, et al. 2022. Development. 149:. PubMed
  27. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  28. Cook ME, et al. 2022. Sci Immunol. 7:eabo0981. PubMed
  29. Whyte CE, et al. 2022. Curr Protoc. 2:e589. PubMed
  30. Lao L, et al. 2023. Cancer Immunol Res. 11:320. PubMed
  31. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  32. Schwarz A, et al. 2023. Front Immunol. 14:1038689. PubMed
  33. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  34. Yi X, et al. 2023. Signal Transduct Target Ther. 8:107. PubMed
  35. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  36. McKenzie C, et al. 2023. Mol Ther Nucleic Acids. 32:603. PubMed
  37. Wu C, et al. 2023. Cancer Metab. 11:7. PubMed
  38. Adu-Berchie K, et al. 2023. Nat Commun. 14:3546. PubMed
  39. Arruda, L. C. M., Karbach, J., et al. 2025. Oncoimmunology. 14(1),2559784. PubMed
  40. Fines, C., Umbreen, S., et al. 2025. Cells. 14(20),0. PubMed
  41. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  42. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  43. Bujanover N, et al. 2021. Stem Cell Reports. 16:1884. PubMed
  44. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  45. Zhang M, et al. 2020. Nat Commun. 4.707638889. PubMed
  46. Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed
  47. Guo R, et al. 2020. Nat Microbiol. 0.938194444. PubMed
  48. van der Heiden M, et al. 2020. Scand J Immunol. e13005:. PubMed
  49. Baram T, et al. 2021. Cells. 10:. PubMed
  50. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  51. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  52. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  53. Fronik P, et al. 2021. J Med Chem. 64:12132. PubMed
  54. Webster MR, et al. 2020. Mol Cell. 77:633. PubMed
  55. Lin H, et al. 2020. Front Microbiol. 1.330555556. PubMed
  56. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  57. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  58. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  59. Cortez JT, et al. 2020. Nature. 582:416. PubMed
  60. Prodinger J, et al. 2016. J Leukoc Biol. 99: 583-594. PubMed
  61. Noman MZ, et al. 2020. Sci Adv. 6:eaax7881. PubMed
  62. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  63. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  64. Ng W, et al. 2021. Pharm Biol. 59:47:00. PubMed
  65. Tian X, et al. 2021. Annals of Translational Medicine. 9(9):781. PubMed
  66. Wei SC, et al. 2020. Cancer Discov. . PubMed
  67. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  68. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  69. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  70. Freitas JT, et al. 2021. Pigment Cell Melanoma Res. 34:1084. PubMed
  71. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  72. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  73. Shevyrev D, et al. 2021. Exp Ther Med. 209:21. PubMed
  74. Jarjour NN, et al. 2019. Nat Immunol. 1.310416667. PubMed
  75. de Andrade LF, et al. 2019. JCI Insight. 4:e133103. PubMed
  76. Pucella JN, et al. 2019. J Immunol. 202:1383. PubMed
  77. Shiao SL, et al. 2021. Cancer Cell. 39:1202. PubMed
  78. Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed
  79. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  80. Swartz AM, et al. 2022. Curr Protoc. 2:e410. PubMed
  81. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  82. Woodruff M, et al. 2020. medRxiv. . PubMed
  83. Wiarda JE, et al. 2022. Life Sci Alliance. 5:. PubMed
  84. Ellis GI, et al. 2022. STAR Protoc. 3:101784. PubMed
  85. Lü X, et al. 2021. Exp Ther Med. 22:1005. PubMed
  86. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  87. Hu HJ, et al. 2021. Cancer Immunol Immunother. 70:3541. PubMed
  88. Ye Z, et al. 2021. Nat Commun. 12:907. PubMed
  89. Qiao J, et al. 2019. Cancer Cell. 35:901. PubMed
  90. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  91. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  92. Bin L, et al. 2017. APMIS. 10.1111/apm.12748. PubMed
  93. Saito E, et al. 2019. Biomaterials. 222:119432. PubMed
  94. Kleiman E, et al. 2021. Sci Rep. 11:9561. PubMed
  95. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  96. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  97. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  98. Rasmussen TA, et al. 2022. Cell Rep Med. 3:100766. PubMed
  99. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  100. de Picciotto S, et al. 2022. Nat Commun. 13:3866. PubMed
  101. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  102. Ye Z, et al. 2021. NPJ Aging Mech Dis. 7:4. PubMed
  103. Xu L, et al. 2020. Nat Cell Biol. 1162:22. PubMed
  104. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  105. Okuma A, et al. 2017. Nat Commun.. 10.1038/s41467-017-02281-x. PubMed
  106. Yao C, et al. 2018. Autophagy. 1.854861111. PubMed
  107. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  108. Datlinger P, et al. 2017. Nat Methods. 10.1038/nmeth.4177. PubMed
  109. Jarjour NN, et al. 2020. J Immunol. 204:923. PubMed
  110. Oherle K, et al. 2020. Immunity. 275:52. PubMed
  111. Minns D, et al. 2021. Nat Commun. 12:1285. PubMed
  112. Dhar P, et al. 2021. Commun Biol. 4:905. PubMed
  113. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  114. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  115. Capelle CM, et al. 2021. Immunohorizons. 5:711. PubMed
  116. Lone W, et al. 2021. Clin Cancer Res. 27:6039. PubMed
  117. Chen Y, et al. 2021. Nat Immunol. 22:996. PubMed
  118. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  119. Alhudaithi SS, et al. 2020. Mol Pharm. 17:4691. PubMed
  120. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  121. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  122. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  123. Feng Y, et al. 2019. Stem Cell Res Ther. 0.479166667. PubMed
  124. Andricovich J, et al. 2016. J Clin Invest. 126:905-20. PubMed
  125. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  126. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  127. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  128. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  129. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  130. Zhu P, et al. 2022. Cell Commun Signal. 20:121. PubMed
  131. Zhao J, et al. 2021. Front Oncol. 10:621092. PubMed
  132. Prosser A, et al. 2021. STAR Protoc. 2:100810. PubMed
  133. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  134. Gonzalez MM, et al. 2021. J Clin Invest. 131:. PubMed
  135. Moritsch S, et al. 2022. Oncoimmunology. 11:2127271. PubMed
  136. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  137. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  138. Vora AA, et al. 2021. STAR Protocols. 2(2):100565. PubMed
  139. Zeng Y, et al. 2019. FASEB J. 33:6596. PubMed

Antigen Details

Cell Type
Tregs
Biology Area
Immunology, Transcription Factors
Molecular Family
Nuclear Markers
Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 5    Revision Date: 05/20/2020

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account